🕒 Last update: loading…22/11/2026

Stock Affluent Medical S.A. AFME.PA

Affluent Medical S.A. — Investlytic score 0/5 on the five criteria.

-
-
0/ 100
Score Investlytic · 5 criteria

Analysis in progress…

Investlytic score: 0/5 criteria met. Data as of 01/11/2026.

  • ❌ Price trend failed
  • ⚠️ Mixed growth
  • ❌ Debt failed
  • ❌ P/E failed
  • ❌ Correction failed

Price trend

Overall trend (8 years): insufficient progression (less than x1.5).

Price change 2021 → 2022: -70.47%

Price change 2022 → 2023: 10.12%

Price change 2023 → 2024: -27.03%

Price change 2024 → 2025: 28.15%

Price change 2025 → 2026: 84.97%

Price change 2026 (year to date): 79.78%

Financial growth

Revenue CAGR (8 years): 146.72%

Earnings CAGR (8 years): N/A

Growth status: positive trend (>1%/yr) in revenue, earnings data insufficient/N/A.

Debt

Debt-to-equity ratio: 0.54

Debt/equity > 0.5 (maximum threshold).

P/E (Price/Earnings)

P/E ratio: -7.81

P/E > 25.0 (maximum threshold).

Correction (6 months)

Price history over 6 months not available.

WATCH
The stock is currently being evaluated.

Criteria of the Investlytic model

- / 5
🔒

Investlytic rating reserved for members

Score out of 100, model verdict (buy, watch, sell) and details of the 5 criteria · visible with a free account.

02

Price trend

Price & trend

Interactive chart →
Loading chart…
03

Detailed analysis · Price trend

-

🔒

Reserved for members

Global model trend and annual price variations · visible with a free account.

04

Revenues & profits

Revenue and net income

🔒

Reserved for members

Chart of revenues and net income over 8 periods · real data, no estimates.

05

Financial indicators

🔒

Reserved for members

18 financial indicators analyzed by groups of criteria: valuation, profitability, growth, solidity, dividend, and momentum.

06

Annual financial statements

Fiscal yearRevenueNet income Net marginEPSRevenue growth
🔒

Reserved for members

Complete annual financial statements: revenue, net income, margin, and EPS over 8 fiscal years.

+

Dividends and earnings

Affluent Medical S.A.: dividend history, last distributions, stock splits and earnings releases.

No known dividend for this company.

Stock splits

DateOperation
31/08/2022split: 1,023 shares for 1,000

Factual data: ex-dividend history and earnings calendar, as of 21/11/2026. A past dividend does not guarantee the next one.

+

PEA and practical information

PEA eligibility
likely
head office in the EU or EEA, listed on a European exchange
Listing exchange
Euronext Paris
IPO: 14/06/2021
ISIN code
FR0013333077
Workforce
66
full-time employees
Chief executive
Sebastien Ladet

Rule applied: the French PEA accepts shares of companies headquartered in the European Union or the European Economic Area and subject to corporate income tax; ADRs and tax-exempt property companies (SIIC) are excluded. The institution holding the PEA confirms eligibility.

?

Frequently asked questions about Affluent Medical S.A.

Is Affluent Medical S.A. stock eligible for the French PEA?

Likely: the company is headquartered in the European Union or the European Economic Area (ISIN FR0013333077) and the stock is listed on a European exchange. The institution holding the PEA confirms eligibility.

How many employees does Affluent Medical S.A. have?

66 full-time employees according to the latest published profile.

Who runs Affluent Medical S.A.?

Sebastien Ladet is the company's chief executive.